Home › Eierstokkanker › New Mexico › Albuquerque
Eierstokkanker klinische studies in Albuquerque, NM
15 studies voor Eierstokkanker zoeken deelnemers op locaties in en rond Albuquerque (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RekruterenFase 2/3
- University of New Mexico Cancer Center, Albuquerque
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- University of New Mexico Cancer Center, Albuquerque
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RekruterenFase 2
- Optimum Clinical Research Group /ID# 274583, Albuquerque
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RekruterenFase 2
- Research Site, Albuquerque
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruterenFase 3
- Optimum Clinical Research Group, Albuquerque
Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer
RekruterenObservatieonderzoek
- University of New Mexico Cancer Center, Albuquerque
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekruterenFase 3
- Unm Comprehensive Cancer Center, Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekruterenFase 1/2
- Research Site, Albuquerque
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RekruterenFase 3
- University of New Mexico Comprehensive Cancer Center ( Site 0055), Albuquerque
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekruteren
- University of New Mexico Cancer Center, Albuquerque
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruterenFase 3
- University of New Mexico Cancer Center, Albuquerque
Clinical Pre-screening Protocol for Ovarian Cancer
RekruterenObservatieonderzoek
- University of New Mexico Comprehensive Cancer, Albuquerque
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruterenFase 2
- 292, Albuquerque
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RekruterenFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Albuquerque
Eierstokkanker studies in andere steden
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Andere studies in Albuquerque
- Niet-kleincellige longkanker18 studies
- Borstkanker17 studies
- Kanker (alle vormen)14 studies
- Longkanker14 studies
- Metastatische kanker12 studies
- Endometriumkanker12 studies
- Type 2-diabetes11 studies
- Cardiovasculaire ziekte10 studies
- Melanoom9 studies
- Acute myeloïde leukemie9 studies
- Prostaatkanker9 studies
- Chronische nierziekte8 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.